Page 1 | Search Results | Blood | American Society of Hematology

1-12 of 12

Sort by

Sort Order Select

Journal Articles

Effects of eltrombopag on platelet count and platelet activation in Wiskott-Aldrich syndrome/X-linked thrombocytopenia

Anja J. Gerrits, Emily A. Leven, Andrew L. Frelinger, III, Sophie L. Brigstocke, Michelle A. Berny-Lang, W. Beau Mitchell, Shoshana Revel-Vilk, Hannah Tamary, Sabrina L. Carmichael, Marc R. Barnard, Alan D. Michelson, James B. Bussel

Blood (2015) 126 (11): 1367–1378.

https://doi.org/10.1182/blood-2014-09-602573

Published: 2015

Journal Articles

Clopidogrel Pharmacokinetics and Pharmacodynamics Vary Widely Despite Exclusion or Control of Polymorphisms ( CYP2C19 , ABCB1 , PON1 ), Non-Compliance, Diet, Smoking, Co-Medications (including Proton Pump Inhibitors), and Pre-Existent Variability in Platelet Function

Andrew L. Frelinger, III, PhD, Deepak L. Bhatt, MD, MPH, Ronald D. Lee, PhD, Darcy J. Mulford, PhD, Jingtao Wu, PhD, Sai Nudurupati, PhD, Anu Nigam, MS, Michael Lampa, BS, Julie K. Brooks, MS, Marc R. Barnard, MS, Alan D. Michelson, MD

Blood (2012) 120 (21): 4356.

https://doi.org/10.1182/blood.V120.21.4356.4356

Published: 2012

Journal Articles

Platelet Activation and Inhibition in Sickle Cell Disease (PAINS) Study

Andrew L. Frelinger, III, PhD, Joseph A. Jakubowski, PhD, Julie K. Brooks, MS, Sabrina L. Zayas, BS, Michelle A. Berny-Lang, PhD, Marc R. Barnard, MS, Matthew M. Heeney, MD, Alan D. Michelson, MD

Blood (2012) 120 (21): 5147.

https://doi.org/10.1182/blood.V120.21.5147.5147

Published: 2012

Journal Articles

In vivo effects of eltrombopag on platelet function in immune thrombocytopenia: no evidence of platelet activation

Bethan Psaila, James B. Bussel, Matthew D. Linden, Bracken Babula, Youfu Li, Marc R. Barnard, Chinara Tate, Kanika Mathur, Andrew L. Frelinger, Alan D. Michelson

Blood (2012) 119 (17): 4066–4072.

https://doi.org/10.1182/blood-2011-11-393900

Published: 2012

Includes: Supplemental data

Journal Articles

In Vivo Platelet Activation and Its In Vitro Inhibition by Prasugrel's Active Metabolite In Adolescents with Sickle Cell Disease

Andrew L. Frelinger, III, PhD, Joseph A. Jakubowski, PhD, Julie K. Brooks, MS, Anu Nigam, MS, Michelle A. Berny-Lang, Ph.D., Marc R. Barnard, MS, Matthew M. Heeney, MD, Alan D. Michelson, MD

Blood (2011) 118 (21): 2141.

https://doi.org/10.1182/blood.V118.21.2141.2141

Published: 2011

Journal Articles

Platelet Function and Response to Thrombopoietin Mimetics In Wiskott-Aldrich Syndrome/X-Linked Thrombocytopenia.

James B. Bussel, MD, Andrew L Frelinger, III, PhD, William B Mitchell, MD, Mariana P Pinheiro, MD, Marc R Barnard, MS, Michael Lampa, BS, Bethan Psaila, MD, PhD, Nayla Boulad, BA, Hannah Tamary, MD, Alan D. Michelson, MD

Blood (2010) 116 (21): 1429.

https://doi.org/10.1182/blood.V116.21.1429.1429

Published: 2010

Journal Articles

Agonist and Antagonist Effects of Diadenosine Tetraphosphate, a Platelet Dense Granule Constituent, on Platelet P2Y 1 , P2Y 12 and P2X 1 Receptors

Hung Chang, Ivan B Yanachkov, Alan D Michelson, YouFu Li, Marc R Barnard, George E Wright, Andrew L Frelinger

Blood (2008) 112 (11): 5368.

https://doi.org/10.1182/blood.V112.11.5368.5368

Published: 2008

Journal Articles

Comparison of Platelet Function and Bleeding in Thrombocytopenic Patients with Immune Thrombocytopenic Purpura (ITP) and Chemotherapy-Induced Thrombocytopenia (CIT).

Bethan Psaila, MD, James B. Bussel, MD, Matthew D. Linden, PhD, You Fu Li, MD, Marc R. Barnard, MS, Chinara M. Tate, BA, Lemke K. Page, MD, Eric J. Feldman, MD, Andrew L. Frelinger, PhD, Alan D. Michelson, MD

Blood (2007) 110 (11): 2094.

https://doi.org/10.1182/blood.V110.11.2094.2094

Published: 2007

Journal Articles

In Vivo Effects of Eltrombopag on Human Platelet Function.

Bethan Psaila, MD, James B. Bussel, MD, Matthew D. Linden, PhD, You Fu Li, MD, Marc R. Barnard, MS, Chinara M. Tate, BA, Lemke K. Page, MD, Andrew L. Frelinger, PhD, Alan D. Michelson, MD

Blood (2007) 110 (11): 1301.

https://doi.org/10.1182/blood.V110.11.1301.1301

Published: 2007

Journal Articles

Detection and Mechanisms of GPIIb-IIIa Antagonist Induced Thrombocytopenia: Role for Antibody Induced Platelet Activation.

Matthew D. Linden, PhD, Andrew L. Frelinger, PhD, Mark I. Furman, MD, Lori A. Krueger, MLT ART, Youfu Li, MD, Marsha L. Fox, MS, RN, Annette Hughes, John Lown, MD, Marc R. Barnard, MS, Karin Przyklenk, PhD, Alan D. Michelson, MD

Blood (2005) 106 (11): 1654.

https://doi.org/10.1182/blood.V106.11.1654.1654

Published: 2005

Journal Articles

Platelet activation in cystic fibrosis

Brian P. O'Sullivan, Matthew D. Linden, Andrew L. Frelinger, III, Marc R. Barnard, Michele Spencer-Manzon, James E. Morris, Raneem O. Salem, Michael Laposata, Alan D. Michelson

Blood (2005) 105 (12): 4635–4641.

https://doi.org/10.1182/blood-2004-06-2098

Published: 2005

Journal Articles

Patients with Coronary Artery Disease Have an Increased Incidence of Aspirin Resistance: Association of PFA-100 Closure Time with Clinical Findings.

Andrew L. Frelinger, PhD, Matthew D. Linden, PhD, Mark I. Furman, MD, Marsha L. Fox, RN, Marc R. Barnard, MS, Youfu Li, MD, Kurt Barringhaus, MD, Karin Przyklenk, PhD, Alan D. Michelson, MD

Blood (2004) 104 (11): 1859.

https://doi.org/10.1182/blood.V104.11.1859.1859

Published: 2004

NARROW

Effects of eltrombopag on platelet count and platelet activation in Wiskott-Aldrich syndrome/X-linked thrombocytopenia

Clopidogrel Pharmacokinetics and Pharmacodynamics Vary Widely Despite Exclusion or Control of Polymorphisms ( CYP2C19 , ABCB1 , PON1 ), Non-Compliance, Diet, Smoking, Co-Medications (including Proton Pump Inhibitors), and Pre-Existent Variability in Platelet Function

Platelet Activation and Inhibition in Sickle Cell Disease (PAINS) Study

In vivo effects of eltrombopag on platelet function in immune thrombocytopenia: no evidence of platelet activation

In Vivo Platelet Activation and Its In Vitro Inhibition by Prasugrel's Active Metabolite In Adolescents with Sickle Cell Disease

Platelet Function and Response to Thrombopoietin Mimetics In Wiskott-Aldrich Syndrome/X-Linked Thrombocytopenia.

Agonist and Antagonist Effects of Diadenosine Tetraphosphate, a Platelet Dense Granule Constituent, on Platelet P2Y 1 , P2Y 12 and P2X 1 Receptors

Comparison of Platelet Function and Bleeding in Thrombocytopenic Patients with Immune Thrombocytopenic Purpura (ITP) and Chemotherapy-Induced Thrombocytopenia (CIT).

In Vivo Effects of Eltrombopag on Human Platelet Function.

Detection and Mechanisms of GPIIb-IIIa Antagonist Induced Thrombocytopenia: Role for Antibody Induced Platelet Activation.

Platelet activation in cystic fibrosis

Patients with Coronary Artery Disease Have an Increased Incidence of Aspirin Resistance: Association of PFA-100 Closure Time with Clinical Findings.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only